We need to give women the choice to use DTG or not and to use contraception if indicated and desired. We need to support choices across options, with risk reduction—not use of a specific product—as the primary outcome. We need to give women the choice to use DMPA-IM or –SC or not, and to use HIV prevention as desired.
Putting Women at the Center: Informed choice in 2018 and beyond
PrEP Initiations by Country in Africa
AVAC tracks global PrEP use by conducting quarterly surveys of ongoing oral PrEP demonstration and implementation projects, and collecting data from manufacturers and government agencies. This graphic shows data on PrEP initiations in Africa. For more trends in oral PrEP uptake, check out the Oral PrEP Enrollment Snapshot slide deck and visit PrEPWatch.
A Global Look at PrEP Introduction
The introduction of PrEP took many years to reach current levels of acceptance and availability. The next phase of distribution is on track to move faster. This is an updated version of a graphic appearing in AVAC Report 2017: Mixed messages and how to untangle them.
Map of HIV Prevention Research and PrEP Demonstration Sites in Kenya
This map demonstrates the breadth of HIV prevention research and demonstration projects in Kenya by site and type (e.g. daily oral PrEP, preventive Vaccines, etc.). This map was developed by Wits RHI with support from AVAC as part of the Coalition to Accelerate and Support Prevention Research.
Map of HIV Prevention Research and PrEP Demonstration Sites in Malawi
This map demonstrates the breadth of HIV prevention research in Malawi by site and type (e.g. ARV-based vaginal rings, long-acting injectable PrEP, preventive Vaccines, antibodies). This map was developed by Wits RHI with support from AVAC as part of the Coalition to Accelerate and Support Prevention Research.
Map of HIV Prevention Research and PrEP Demonstration Sites in Uganda
This map demonstrates the breadth of HIV prevention research and demonstration projects in Uganda by site and type (e.g. daily oral PrEP, preventive Vaccines, etc.). This map was developed by Wits RHI with support from AVAC as part of the Coalition to Accelerate and Support Prevention Research.
Map of HIV Prevention Research and PrEP Demonstration Sites in Zambia
This map demonstrates the breadth of HIV prevention research and demonstration projects in Zambia by site and type (e.g. daily oral PrEP, preventive Vaccines, etc.). This map was developed by Wits RHI with support from AVAC as part of the Coalition to Accelerate and Support Prevention Research.
Map of HIV Prevention Research and PrEP Demonstration Sites in Zimbabwe
This map demonstrates the breadth of HIV prevention research and demonstration projects in Zimbabwe by site and type (e.g. daily oral PrEP, preventive Vaccines, etc.). This map was developed by Wits RHI with support from AVAC as part of the Coalition to Accelerate and Support Prevention Research.
Vaccines Efficacy Trials: A surge of activity
A picture of the status of vaccine trials since 2003: The four trials shown here represent an unprecedented number of late phase trials underway in vaccines research.
Prevention Research & Oral PrEP Rollout: The evolving context for HIV prevention research
Many of the current or planned prevention trials are taking place in countries where daily oral PrEP is available or will be soon. This infographic shows the status PrEP and the location of scheduled trials by country.